Search results

44 items matching your search terms.
Filter the results.
Item type













New items since



Sort by relevance · date (newest first) · alphabetically
Lisa Carey, international breast cancer expert, appointed to Susan G. Komen’s Scientific Advisory Board
As a member of Susan G. Komen's Scientific Advisory Board, UNC Lineberger's Lisa A. Carey, MD, will be responsible for helping guide Komen’s $956 million research program – second only to the U.S. government in funding of breast cancer research.
Located in News
Located in Newsroom / UNC Lineberger in the News
To halt breast cancer’s spread, scientists block amino acid found in asparagus
UNC Lineberger researchers, including Charles M. Perou, PhD, and Lisa A. Carey, MD, were part of a preclinical study that found blocking the production of asparagine with a drug called L-asparaginase in mice with aggressive triple negative breast tumors, and putting them on a low-asparagine diet, reduced the breast tumor’s ability to spread.
Located in News
UNC Lineberger researchers identify genetic ‘seeds’ of metastatic breast cancer
In the Journal of Clinical Investigation, UNC Lineberger researchers Lisa A. Carey, MD, Charles M. Perou, PhD, and Carey Anders, MD, Marni Siegel and colleagues published their analysis of the genetic differences they discovered in patients’ primary breast cancers and their metastatic cancers.
Located in News
Health indicators for newborns of breast cancer survivors may vary by cancer type
In a study published in the International Journal of Cancer, researchers led by UNC Lineberger's Hazel Nichols, PhD, analyzed health indicators for children born to young breast cancer survivors in North Carolina.
Located in News
Located in Newsroom / UNC Lineberger in the News
Study sheds light on why some breast cancers have limited response to immunotherapy
Jonathan Serody, MD, Benjamin Vincent, MD, and a team of UNC Lineberger investigators published findings in the Journal of Clinical Investigation that may explain why drugs designed to unleash the immune system against cancer were ineffective in treating a type of triple negative breast cancer. They determined “claudin-low” tumors were releasing a chemical signal to attract regulatory T-cells, which prevented the immune system from rejecting the cancer.
Located in News
Racial gaps persist in how breast cancer survivors function, feel during treatment and after
A UNC Lineberger study published in the journal Breast Cancer Research and Treatment drew upon surveys that assessed health-related quality of life issues for women aged 20 to 74 years who lived in North Carolina and had breast cancer. The analysis was part of the third phase of the Carolina Breast Cancer Study.
Located in News
Breast cancer researchers receive $2.5 million in Susan G. Komen grants
Susan G. Komen has announced more than $2.5 million in grants for UNC Lineberger Comprehensive Cancer Center researchers. The organization, which funded eight grants for nearly $2.97 million to researchers in North Carolina, has a goal of reducing breast cancer deaths in the U.S. by 50 percent across the next decade.
Located in News
Located in Newsroom / UNC Lineberger in the News